PubMed · 16972710
Challenges in implementing adaptive designs: comments on the viewpoints expressed by regulatory statisticians.
Abstract
This is a discussion of the following three papers appearing in this special issue on adaptive designs: 'FDA's critical path initiative: A perspective on contributions of biostatistics' by Robert T. O'Neill; 'A regulatory view on adaptive/flexible clinical trial design' by H. M. James Hung, Robert T. O'Neill, Sue-Jane Wang and John Lawrence; and 'Confirmatory clinical trials with an adaptive design' by Armin Koch.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Paul Gallo, Willi Maurer. 2006. Challenges in implementing adaptive designs: comments on the viewpoints expressed by regulatory statisticians.. https://doi.org/10.1002/bimj.200610250
Cite the original work for its findings. Save a collection to share your selection of sources.